Last reviewed · How we verify
NCT06364735
Entities and Variables Related to Catch-up Growth
trial in Celiac Disease in Children in 900 participants. Currently enrolling.
1 December 2024
Quick facts
| Lead sponsor | ASST Fatebenefratelli Sacco |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 900 |
| Start date | 1 July 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across Italy |
Conditions studied
- Celiac Disease in Children — all drugs for Celiac Disease in Children →
Sponsor
ASST Fatebenefratelli Sacco — full company profile →
Who can join
18 and older, any sex, with Celiac Disease in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A retrospective monocentric observational no-profit study with the aim of evaluating the entity and potential variables influencing the catch-up growth of childhood gluten-free diet patients with celiac disease during a 10-year follow-up. The only extrapolation of the data collected in anonymized form from the medical records of patients who match the necessary study criteria will be planned in order to achieve this aim. A 900-patient sample size will be planned.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06364735
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Celiac Disease in Children
Currently open trials in the same condition.
- NCT06849622 — Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease · NA · recruiting
- NCT06568263 — Celiac Disease and Quality of Life in Children and Adolescents (CeliaQLife) · recruiting
- NCT04806620 — Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research · recruiting
- NCT05209568 — Immune Responses to Gluten · NA · recruiting
- NCT04593888 — Gluten Reduction and Risk of Celiac Disease · NA · active not recruiting
Other ASST Fatebenefratelli Sacco trials
Trials by the same sponsor.
- NCT07472348 — Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors · not yet recruiting
- NCT07033416 — A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder · NA · recruiting
- NCT06398054 — A Study to Investigate the Analgesic Efficacy of Ibuprofen Alone and Ibuprofen Plus Hyoscine-n- Butyl Bromide in Reducin · Phase 4 · not yet recruiting
- NCT07343739 — Bipolar Disorder Integrative Staging: Incorporating Biomarkers Into Progression Across Stages · active not recruiting
- NCT05925790 — Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06364735 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ASST Fatebenefratelli Sacco
- Last refreshed: 19 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06364735.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing